Cargando…
Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649381/ http://dx.doi.org/10.1186/2051-1426-3-S2-P254 |
| _version_ | 1782401346090041344 |
|---|---|
| author | Lepone, Lauren Donahue, Renee Grenga, Italia Jochems, Caroline Tsang, Kwong-Yok Metenou, Simon Richards, Jacob Heery, Christopher R Madan, Ravi Gulley, James L Schlom, Jeffrey |
| author_facet | Lepone, Lauren Donahue, Renee Grenga, Italia Jochems, Caroline Tsang, Kwong-Yok Metenou, Simon Richards, Jacob Heery, Christopher R Madan, Ravi Gulley, James L Schlom, Jeffrey |
| author_sort | Lepone, Lauren |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649381 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46493812015-11-24 Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells Lepone, Lauren Donahue, Renee Grenga, Italia Jochems, Caroline Tsang, Kwong-Yok Metenou, Simon Richards, Jacob Heery, Christopher R Madan, Ravi Gulley, James L Schlom, Jeffrey J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649381/ http://dx.doi.org/10.1186/2051-1426-3-S2-P254 Text en Copyright © 2015 Lepone et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Lepone, Lauren Donahue, Renee Grenga, Italia Jochems, Caroline Tsang, Kwong-Yok Metenou, Simon Richards, Jacob Heery, Christopher R Madan, Ravi Gulley, James L Schlom, Jeffrey Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells |
| title | Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells |
| title_full | Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells |
| title_fullStr | Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells |
| title_full_unstemmed | Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells |
| title_short | Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells |
| title_sort | evaluation of immune cell subsets of cancer patients treated with avelumab, a fully human igg1 anti-pd-l1 mab capable of mediating adcc of human tumor cells |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649381/ http://dx.doi.org/10.1186/2051-1426-3-S2-P254 |
| work_keys_str_mv | AT leponelauren evaluationofimmunecellsubsetsofcancerpatientstreatedwithavelumabafullyhumanigg1antipdl1mabcapableofmediatingadccofhumantumorcells AT donahuerenee evaluationofimmunecellsubsetsofcancerpatientstreatedwithavelumabafullyhumanigg1antipdl1mabcapableofmediatingadccofhumantumorcells AT grengaitalia evaluationofimmunecellsubsetsofcancerpatientstreatedwithavelumabafullyhumanigg1antipdl1mabcapableofmediatingadccofhumantumorcells AT jochemscaroline evaluationofimmunecellsubsetsofcancerpatientstreatedwithavelumabafullyhumanigg1antipdl1mabcapableofmediatingadccofhumantumorcells AT tsangkwongyok evaluationofimmunecellsubsetsofcancerpatientstreatedwithavelumabafullyhumanigg1antipdl1mabcapableofmediatingadccofhumantumorcells AT metenousimon evaluationofimmunecellsubsetsofcancerpatientstreatedwithavelumabafullyhumanigg1antipdl1mabcapableofmediatingadccofhumantumorcells AT richardsjacob evaluationofimmunecellsubsetsofcancerpatientstreatedwithavelumabafullyhumanigg1antipdl1mabcapableofmediatingadccofhumantumorcells AT heerychristopherr evaluationofimmunecellsubsetsofcancerpatientstreatedwithavelumabafullyhumanigg1antipdl1mabcapableofmediatingadccofhumantumorcells AT madanravi evaluationofimmunecellsubsetsofcancerpatientstreatedwithavelumabafullyhumanigg1antipdl1mabcapableofmediatingadccofhumantumorcells AT gulleyjamesl evaluationofimmunecellsubsetsofcancerpatientstreatedwithavelumabafullyhumanigg1antipdl1mabcapableofmediatingadccofhumantumorcells AT schlomjeffrey evaluationofimmunecellsubsetsofcancerpatientstreatedwithavelumabafullyhumanigg1antipdl1mabcapableofmediatingadccofhumantumorcells |